Flagship Private Wealth, LLC Bristol Myers Squibb CO Transaction History

Flagship Private Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 20, 2021	SELL	$59.17 - $69.31 $2,721 - $3,188	-46 Closed	0 $0
Q2 2021 Jul 09, 2021	SELL	$61.91 - $67.42 $188,330 - $205,091	-3,042 Reduced 98.51%	46 $3.09 Million
Q2 2021 Jul 09, 2021	BUY	$61.91 - $67.42 $188,330 - $205,091	3,042 Added 6613.04%	3,088 $206,000
Q4 2020 Feb 02, 2021	BUY	$57.74 - $65.43 $2,656 - $3,009	46 New	46 $2,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Flagship Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Private Wealth, LLC with notifications on news.